ERBB2 and breast carcinoma: In addition, it was also reported that designed novel TPR modules, which binds to the C-terminus of Hsp90 with high affinity, decreased HER2 levels in BT474 HER2-positive breast cancer cells, resulting in the killing of these cells [44].